# Study on the Clinical and Mechanism of Wenyang Huoxue Decoction in Treating Heart Failure After Myocardial Infarction

> **NCT04695990** · PHASE2 · UNKNOWN · sponsor: **Jun Li** · enrollment: 200 (estimated)

## Conditions studied

- Heart Failure
- Myocardial Infarction

## Interventions

- **DRUG:** Wenyang Huoxue Decoction
- **DRUG:** Wenyang Huoxue placebo

## Key facts

- **NCT ID:** NCT04695990
- **Lead sponsor:** Jun Li
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01-15
- **Primary completion:** 2022-03-01
- **Final completion:** 2022-12-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2021-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04695990

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04695990, "Study on the Clinical and Mechanism of Wenyang Huoxue Decoction in Treating Heart Failure After Myocardial Infarction". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT04695990. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*